Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma

Guardado en:

Detalles Bibliográficos
Autores principales:	Koji Nakajima, Ayumi Korekawa, Daiki Rokunohe, Hajime Nakano, Daisuke Sawamura
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	anemia jaundice melanoma metastasis nivolumab Dermatology RL1-803 Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/07689a31d97d491c824f04b261b45b9e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:07689a31d97d491c824f04b261b45b9e
record_format	dspace
spelling	oai:doaj.org-article:07689a31d97d491c824f04b261b45b9e2021-11-08T15:10:52ZAutoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma2574-459310.1002/cia2.12173https://doaj.org/article/07689a31d97d491c824f04b261b45b9e2021-10-01T00:00:00Zhttps://doi.org/10.1002/cia2.12173https://doaj.org/toc/2574-4593Koji NakajimaAyumi KorekawaDaiki RokunoheHajime NakanoDaisuke SawamuraWileyarticleanemiajaundicemelanomametastasisnivolumabDermatologyRL1-803Immunologic diseases. AllergyRC581-607ENJournal of Cutaneous Immunology and Allergy, Vol 4, Iss 5, Pp 139-140 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	anemia jaundice melanoma metastasis nivolumab Dermatology RL1-803 Immunologic diseases. Allergy RC581-607
spellingShingle	anemia jaundice melanoma metastasis nivolumab Dermatology RL1-803 Immunologic diseases. Allergy RC581-607 Koji Nakajima Ayumi Korekawa Daiki Rokunohe Hajime Nakano Daisuke Sawamura Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
format	article
author	Koji Nakajima Ayumi Korekawa Daiki Rokunohe Hajime Nakano Daisuke Sawamura
author_facet	Koji Nakajima Ayumi Korekawa Daiki Rokunohe Hajime Nakano Daisuke Sawamura
author_sort	Koji Nakajima
title	Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
title_short	Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
title_full	Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
title_fullStr	Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
title_full_unstemmed	Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
title_sort	autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/07689a31d97d491c824f04b261b45b9e
work_keys_str_mv	AT kojinakajima autoimmunehemolyticanemiaduringlongtermadministrationofnivolumabformetastaticmelanoma AT ayumikorekawa autoimmunehemolyticanemiaduringlongtermadministrationofnivolumabformetastaticmelanoma AT daikirokunohe autoimmunehemolyticanemiaduringlongtermadministrationofnivolumabformetastaticmelanoma AT hajimenakano autoimmunehemolyticanemiaduringlongtermadministrationofnivolumabformetastaticmelanoma AT daisukesawamura autoimmunehemolyticanemiaduringlongtermadministrationofnivolumabformetastaticmelanoma
_version_	1718442110373330944

Autoimmune hemolytic anemia during long‐term administration of nivolumab for metastatic melanoma

Ejemplares similares